Brief: Ikena Oncology Inc Says On June 30, Got Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq
June 30 (Reuters) - Ikena Oncology Inc IKNA.O :
* IKENA ONCOLOGY INC- ON JUNE 30, GOT NOTICE OF DELISTING OR
FAILURE TO SATISFY A CONTINUED LISTING RULE OR STANDARD FROM
NASDAQ
Source text for Eikon: ID:
Further company coverage: IKNA.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on ImageneBio
See all newsImageneBio Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: ImageneBio - Appoints Yanina Grant-Huerta As Chief Financial Officer Effective July 20, 2026 - SEC Filing
ImageneBio Inc expected to post a loss of 89 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune
U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma